Trademark Search in Canada

RHEACELL INNOVATIVE STEM CELL THERAPIES

View On IC.GC.CA

REGISTERED

on 10 Nov 2023

Last Applicant/ Owned by

RHEACELL GMBH & CO. KG

Im Neuenheimerfeld 51769120 Heidelberg

Serial Number

2092645 filed on 11^th Dec 2020

Registration Number

TMA1208339 registered on 10^th Nov 2023

Registration expiry Date

11^th Dec 2030

Correspondent Address

ERIN MCEWEN

NELLIGAN O'BRIEN PAYNE LLP 50 O'Connor StreetSuite 300Ottawa,

ONTARIO

K1P6L2

RHEACELL INNOVATIVE STEM CELL THERAPIES

Trademark usage description

drugs, namely, drug delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical and veteri Read More

Classification Information

Class [005]
Drugs, namely, drug delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical and veterinary preparations for the treatment of skin diseases, vertigo, nausea, migraines, disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, of blood diseases and disorders, pharmaceutical and veterinary preparations, namely, antibiotics, immune suppressants, anti-inflammatory preparations, pharmaceutical and veterinary preparations for wound healing, pharmaceutical and veterinary preparations for anti-aging, namely stem cells for medical and medical aesthetic purposes, fibroblasts for medical and aesthetic purposes, surgical tissue implants comprised of living tissue obtained from fibroblasts; diagnostic agents for medical purposes; diagnostic preparations for medical and biomedical purposes; pharmaceutical cell preparations for medical use for the treatment of skin diseases, vertigo, nausea, vomiting, migraine, disease and disorders of the respiratory system, disease and disorders of the gastrointestinal system, disease and disorders of the endocrine system, disease and disorders of the cardiovascular system, disease and disorders of the nervous system, disease and disorders of musculoskeletal system, disease and disorders of urinary system, disease and disorders of integumentary system, disease and disorders of the reproductive system, blood diseases and disorders; sterilizing substances for medical use; sterilizing substances for biomedical purposes; live implants comprising of live tissues for pharmaceutical purposes; biochemical and chemical products, namely biochemical preparations for the treatment of skin diseases and chemical reagents for medical use; biochemical and chemical products, namely biochemical preparations for the treatment of skin diseases and chemical reagents for pharmaceutical purposes; biochemical and chemical products for pharmaceutical or medical purposes, namely, biochemical preparations for the treatment of skin diseases, vertigo, nausea, vomiting, migraine, disease and disorders of the respiratory system, disease and disorders of the gastrointestinal system, disease and disorders of the endocrine system, disease and disorders of the cardiovascular system, disease and disorders of the nervous system, disease and disorders of musculoskeletal system, disease and disorders of urinary system, disease and disorders of integumentary system, and disease and disorders of the reproductive system, blood diseases and disorders for diagnostic purposes; proteins being protein supplements for medical purposes; biological preparations for medical and veterinary purposes, and pharmaceutical and veterinary preparations, all for external use for the treatment of skin diseases, wounds ulcers, burns and surgical wounds; anti-aging medicated skin care preparations; medical dressings; pharmaceutical preparations for wound treating and healing; biological, pharmaceutical and veterinary preparations for the treatment of chronic wounds, ulcers, burns and surgical wounds; stem cells for medical purposes; stem cells for veterinary purposes; stem cells for aesthetic purposes; somatic stem cell therapeutics; pharmaceutical implants, namely implantable surgery human allograft bones, biological bone tissue grafts, cells for medical use, biological bone marrow tissue; surgical implants comprised of living stem cells; surgical implants comprised of living fibroblasts tissue cells; biological human skin and bone tissue intended for subsequent implantation; growth media for culturing cells for medical purposes, namely, bone growth media consisting of biological materials for medical purposes; pharmaceutical preparations for tissue regeneration, namely, biodegradable implants for use in guided tissue regeneration; living tissue namely, vascular grafts; biotechnologically engineered tissue products, namely Cell sheets/plasters for wound healing/burns, eye lens grafts, bone grafts;

Classification kind code

Class [042]
Pharmaceutical drug development; scientific and technological services, namely medical and pharmaceutical research services and technical research in the field of pharmaceutical studies, regenerative medicine and tissue engineering; research and development services in the fields of cell diagnostics and therapy and surgical and medical instruments; industrial analysis and research services, namely analysis of industrial fluids and medical research, chemical analysis; scientific research for medical purposes in the field of stem cell therapies; stem cell research; scientific and medical research and development in the field of stem cells; scientific research, testing and analysis services of the services of others to determine conformity with certification standards and in the field of regenerative medicine and tissue engineering; medical research; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology

Classification kind code

Class [044]
Medical services relating to the removal, treatment, processing and storage of human cells and tissue, stem cells and bone marrow, medical services in the field of regenerative medicine; medical diagnostic services for [carrying out tests and analyses]; medical assistance; medical clinic services; hospital services; plastic and cosmetic surgery; medical therapies, namely, therapy for treating medical conditions; medical services relating to the removal, treatment, processing and storage of human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine including tissue engineering; medical services in connection with the removal, treatment, processing and storage of human tissue and stem cells, also in the field of regenerative medicine including tissue engineering; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells

Classification kind code

Mark Details

Serial Number

2092645

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 5^th Apr 2023	Agent Changed
Submitted for opposition 22 on 19^th Jul 2022	Search Recorded
Submitted for opposition 20 on 19^th Jul 2022	Examiner's First Report
Submitted for opposition 223 on 19^th Jul 2022	Total Provisional Refusal
Submitted for opposition 256 on 18^th Jan 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 18^th Mar 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 17^th Mar 2021	Created
Submitted for opposition 31 on 17^th Mar 2021	Formalized
Submitted for opposition 30 on 11^th Dec 2020	Filed
Submitted for opposition 228 on 11^th Dec 2020	International Registration